허혈성 뇌졸중 환자에서 대사증후군과 호모시스테인의 관계
Association Between Metabolic Syndrome and Plasma Homocysteine Level in Patients with Ischemic Stroke
2
조회
0
다운로드
2
인용
0
참고문헌
초록
Abstract
Background: Metabolic syndrome (MS) and homocysteine (Hcy) are known to contribute to developing atherosclerothrombosis in ischemic stroke. However, there have been controversies regarding the relationship between insulin resistance and plasma Hcy levels in healthy subjects. Our aim was to determine the possibility of a relationship between MS and elevated Hcy in ischemic stroke patients. Methods: We investigated demographic features and risk factors in 221 patients from Gachon Stroke Registry between March 2003 and February 2004. The stroke subtypes were categorized as large artery atherosclerosis (LAA), small artery occlusion (SAO) and cardioembolism (CE). MS was defined as the followings; impaired fasting glucose, impaired glucose tolerance or IDDM with two or more among 1) hypertension (antihypertensive treatment and/or BP 160/90 mmHg), 2) dyslipidemia (TG ≥150 mg/dL and/or HDL-C (<35 in men, <39 mg/dL in women)), 3) obesity (BMI ≥25 kg/m2 or waist circumference 90 in men, 80 cm in women). Results: Hcy, total cholesterol, and fibrinogen levels were higher in MS(+) than in MS(-) (p=0.026, 0.021 and 0.025). The Hcy level was higher in LAA patients than in SAO and CE patients (14.1±6.8, 12.0±6.2, 11.0±4.3 mol/L, p=0.009). It was significantly higher in MS(+) than is MS(-) in SAO patients (15.4±9.5 vs 10.5±2.9 mol/L, p=0.016), while not observed in LAA or CE patients. Among the MS(+), LAA was more prevalent (48.6%) than SAO (36.1%) and CE (15.3%). Conclusions: Elevated Hcy level may be associated with ischemic stroke with MS. Further studies remain to be investigated to clarify whether lowering the elevated Hcy can be an another important asset in reducing the risk not only for stroke, but also for MS.
참고문헌 (33)
- "Insulin resistance and risk for stroke", 59, pp.809~815 (2002)
- "more than the sum of its parts", pp.1546~1551 (2003)
- "Oxidative stress markers in Korean subjects in insulin resistance syndrome", 54(2), pp.29~33 (2001)
- "Insulin resistance is associated with elevated plasma total homoysteine levels in healthy non-obese subjects", 139, pp.197~198 (1998)
- "Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men", 22, pp.1004~ (1999)
- "Plasma homocysteine levels in hyperinsulinemic subjects" (1852)
- "Plasma total homocysteine levels in subjects with hyperinsulinemia", 247, pp.287~294 (2000)
- "Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men", 86, pp.719~723 (2001)
- "Homocysteine and vascular disease", 354, pp.407~413 (1999)
- "Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke", 32, pp.57~62 (2001)
- "Report of the Expert Committee on the Diagnosis of Diabetes Mellitus", pp.1183~1197 (1997)
- "diagnosis and classification of diabetes mellitus and its complications diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", pp.539~553 (1998)
- "Estimation of the concentration of low-density lipoprotein cholesterol in plasma,without use of the preparative ultracentrifuge", 18, pp.499~502 (1972)
- "Western Pacific Regional Office of the World Health Organization" (2000)
- "Prevalence of metabolic syndrome according to the new criteria for obesity", 26, pp.431~442 (2002)
- "Classification of subtype of acute ischemic stroke Definitions for use in multicenter clinical trial", pp.35~41
- "Role of insulin resistance in human disease", 37, pp.1595~1607 (1988)
- "Role of insulin resistance in human disease", pp.121~131
- "Acute hyperhomocysteinemia and endothelial dysfunction", 351, pp.36~37 (1998)
- "Hyperhomocyst(e)inaemia is associated with impaired endothelium- dependent vasodilatation in humans", 85, pp.1119~1121 (1997)
- "Hyperhomocyst(e)inaemia after an oral methionine load acutely impairs endothelial function in healthy adults", 98, pp.1848~1852 (1998)
- "Features,symptoms,and neurophysiological findings in stroke associated with hyperhomocysteinemia", 54, pp.1276~1282 (1997)
- "Homocysteine in cerebral macroangiopathy and microan-giopathy", 353, pp.1586~1587 (1999)
- "Association between high homocysteine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischaemic stroke", 31, pp.1069~1075 (2000)
- "A pilot study on total plasma homocysteine level of patients with cerebral infarction", 17, pp.26~31 (1999)
- "Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke", 27, pp.37~43 (1996)
- "Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects", 47, pp.686~689 (1998)
- "Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes", 24, pp.533~538 (2001)
- "The effect of glucose and insulin on the activity of enzymes in homocysteine metabolism", pp.1~
- "Homocysteine and atherothrombosis", 338, pp.1042~1050 (1998)
- "Fasting plasma homocysteine levels in the insulin resistance syndrome.The Framingham Offspring Study", 24, pp.1403~1410 (2001)
- "Effect of metabolic control on homocysteine levels in type 2 diabetic patients", ato s, pp.264~271
- "The homeostasis model in the San Antonio Heart Study", 20, pp.1087~1092 (1997)
